Pharma Globenewswire - Page 22 of 181 - Press Release And News Distribution

Suggestions

Press Release And News Distribution

News
Drug Launches & Approvals
Clinical Trials
Market Insights
Artificial Intelligence
Commercial
More

Latest

Search

Recent Posts

Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast 2034
Sarcopenia Market to Grow from USD 2,276 Million in 2025 to USD 5,626 Million in 2034 | DelveInsight
Non-postoperative Acute Pain Market Size Valued at USD 3,600 Million in 2023 | DelveInsight
Traumatic Brain Injury Market Projected to Reach USD 30 Billion in 2024, Growing at 10.9% CAGR Through 2034
Systemic Sclerosis Market Projected to Reach ~USD 2,660 Million by 2034

Banner

Newsletter

Authors

pharmaglobenews

Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast 2034
Michael Ashford

Motor Neuron Disease Pipeline Insight 2026: Driving Hope Through Next-Generation Therapies

© 2026 - ALL RIGHTS RESERVED.
Pharma GlobeNewswire is a specialized press release distribution platform focused on the pharmaceutical, biotechnology, and healthcare sectors. It enables companies to share news related to drug development, clinical trials, regulatory updates, market insights, and corporate announcements with a global audience. By leveraging targeted distribution channels, Pharma GlobeNewswire helps organizations enhance visibility, reach industry stakeholders, and amplify their brand presence within the life sciences ecosystem.

About
Privacy
Help
Terms
Contact

Popular

FDA Approves Otsuka’s VOYXACT (Sibeprenlimab-szsi): A Breakthrough in Primary Immunoglobulin A Nephropathy Treatment

The pharmaceutical landscape for immunoglobulin A nephropathy (IgAN) treatment has

News
Drug Launches & Approvals
Clinical Trials
Market Insights
Artificial Intelligence
Commercial
More